Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tianeptine for Treatment Resistant Depression
NCT04249596Phase 4Terminated
- Start
- Oct 2020
- Primary completion
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of tianeptine in major depressive disorder (MDD). Started Oct 2020; status: terminated.
02
Drugs
tianeptine
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04249596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249596.